marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q2
hinzugefügt 09.08.2024
Zentalis Pharmaceuticals Bilanz 2011-2024 | ZNTL
Bilanz Jährlich Zentalis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
17.7 M | 4.26 M | -13.8 M | - | -81.6 M | -25.2 M | - | - | - | - | - | - | - |
Langfristige Schulden |
43.2 M | 45.2 M | 44.5 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
2.62 M | 2.16 M | 1.45 M | 902 K | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 4.16 M | 2.48 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
69.4 M | 56.6 M | 43.9 M | 28.6 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
114 M | 105 M | 90 M | 32.2 M | 19.1 M | 8.69 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-889 M | -596 M | -360 M | -201 M | -83 M | -37.3 M | - | - | - | - | - | - | - |
Vermögenswerte |
552 M | 539 M | 455 M | 366 M | 103 M | 41 M | - | - | - | - | - | - | - |
Zahlungsmittel |
28 M | 43.1 M | 59.7 M | 55 M | 67.2 M | 25.2 M | - | - | - | - | - | - | - |
Buchwert |
437 M | 434 M | 364 M | 333 M | 83.6 M | 32.3 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
437 M | 434 M | 364 M | 333 M | -73.3 M | 32.3 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Zentalis Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
41.3 M | 42.6 M | 43.2 M | 43.3 M | 44 M | 44.8 M | 45.2 M | 43 M | 45.1 M | 45 M | 44.5 M | - | - | - | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
109 M | 98.7 M | 114 M | 104 M | 98.2 M | 104 M | 105 M | 100 M | 95 M | 90 M | 90 M | 41.1 M | 36.4 M | 35.7 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-967 M | -878 M | -889 M | -828 M | -772 M | -660 M | -596 M | -541 M | -487 M | -419 M | -360 M | -310 M | -305 M | -251 M | -201 M | -201 M | -201 M | -201 M | -83 M | -83 M | -83 M | -83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
492 M | 557 M | 552 M | 586 M | 621 M | 489 M | 539 M | 529 M | 568 M | 406 M | 455 M | 435 M | 284 M | 328 M | 366 M | 366 M | 366 M | 366 M | 87.5 M | 87.5 M | 87.5 M | 87.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
37 M | 37.6 M | 28 M | 111 M | 267 M | 36.3 M | 43.1 M | 42.6 M | 55.1 M | 30.6 M | 59.7 M | 40.8 M | 49.2 M | 29 M | 56.3 M | 55 M | 55 M | 55 M | 67.2 M | 67.2 M | 67.2 M | 67.2 M | 25.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
383 M | 459 M | 437 M | 482 M | 523 M | 386 M | 434 M | 429 M | 473 M | 316 M | 364 M | 394 M | 248 M | 293 M | 333 M | 333 M | 333 M | 333 M | 68.4 M | 68.4 M | 68.4 M | 68.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
383 M | 459 M | 437 M | 482 M | 523 M | 386 M | 434 M | 429 M | 473 M | 316 M | 364 M | 394 M | 248 M | 293 M | 333 M | 333 M | 309 M | 309 M | -73.3 M | -73.3 M | -73.3 M | -73.3 M | 32.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung